On the 24th of April 2019, the French Technical Agency for Hospital Information (ATIH) has released a technical note in connection with the 2019 DRG changes. Several key updates in relation to the financing of hospitalization benefits as a change of DRGs for fractional flow reserve, package to finance the rehabilitation and infusion costs of the pulmonary system and implementation of two innovative packages for PULSANTE and WISE CRT devices were outlined.

The Clinical Coding and Schedule Development (CCSD) group develop and maintains procedural and diagnostics nomenclature for private payers in England. New procedure codes concern cytoreductive surgery for colorectal peritoneal carcinomatosis, cytoreductive surgery for ovarian malignancies, therapeutic sialendoscopy, intra corporeal salivary gland lithotripsy, and others and diagnostic codes for tests for common and rare mutations.

The report presents a summary of the reimbursement situation for carotid endarterectomy in Europe. The following procedures will be considered in the report: surgical carotid endarterectomy, percutaneous transluminal carotid artery angioplasty and stenting. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

In May 2019, the Galician Agency for Health Technology Assessment, AVALIA-T, has released a report “Laser or radiofrequency ablation in the treatment of recurrent thyroid cancer.”

Director of MTRC will visit HTAi meeting in Cologne on the 19th of June 2019. Reach out to us at info@mtrconsult.com to schedule a meeting to discuss your reimbursement needs in Europe.

Newly released interviews cover topics of organization and financing of health care systems in the Czech Republic, the Netherlands, Spain, the role of HTA in Italy and clinical decision-making for the introduction of novel technologies in the Netherlands.

Descriptions are available as webinars or presentations in Acrobat PDF. They cover stakeholders, money flow, payment system, innovation funding, funding, and HTA landscape. Currently, overviews are available for 15 EU markets: Austria, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, Norway, Romania, Spain, Sweden, and Switzerland. In June-July we will add overviews for Belgium, Greece, the Netherlands, Poland, Russia, and Turkey.

In France, there is a fast-track pathway, which provides reimbursement within the framework of the prospective medico-economic study, aiming at demonstrating benefits to patients or reduction of expenditure of health care system. On the 19th of April, the French National Authority for Health published two opinions regarding the inclusion of two devices into innovation package - eCLIPS: for treatment of cerebral aneurysm, Nuvaira™ Lung Denervation System for chronic obstructive pulmonary disease and asthma.

Four updated pathways for gynecological cancers describe the whole process of management patients – from the first examination for suspicion of cancer to the follow-up and rehabilitation with the management of late effects.

HealthTech Connect, a new online resource provided by NICE to help identify and support new health technologies as they move from inception to adoption in the UK health and care system, was formally launched April 29th, 2019. The system, which is free to use, will help companies to understand what information is needed by decision makers in the UK health and care system, and clarify possible routes to market access.

In April 2019, the Andalusian Agency for Evaluation of Health Technologies, AETSA, has released a report updating the map of genetic tests available in the Spanish National Health System.

The report presents a summary of reimbursement situation for hysterectomy in benign and malignant diseases of uterus. The following types pf procedure will be considered: subtotal hysterectomy, total hysterectomy, radical hysterectomy. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.